Screener
Kestra Medical Technologies KMTS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Research and development | 19,484 | 15,652 |
| Selling, general and administrative | 164,120 | 114,936 |
| Total operating expenses | 183,604 | 130,588 |
| Loss from operations | (134,741) | (106,378) |
| Other expense (income): | ||
| Interest expense | 7,546 | 7,734 |
| Interest income | (8,351) | (3,199) |
| Other expense (income) | (2,618) | 2,766 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's operating income?
- Kestra Medical Technologies (KMTS) reported operating income of -$39.34M in Q1 2026.
- How has Kestra Medical Technologies's operating income changed year-over-year?
- Kestra Medical Technologies's operating income increased by 18.4% year-over-year, from -$48.21M to -$39.34M.
- What is the long-term trend for Kestra Medical Technologies's operating income?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's operating income has grown at a 25.9% compound annual growth rate (CAGR), from -$85.06M to -$134.74M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Kestra Medical Technologies's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude